NCT05130060 - A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

June 11, 2023

Study Completion Date

June 11, 2023

Conditions

Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Microsatellite Stable Colon CarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaMetastatic Rectal AdenocarcinomaMicrosatellite Stable Rectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8

Interventions

BIOLOGICAL

Colorectal Cancer Peptide Vaccine PolyPEPI1018

Given SC

DRUG

Trifluridine and Tipiracil Hydrochloride

Given PO

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester